These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6169955)

  • 21. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical application of adrenoceptor blockers in the treatment of hypertension].
    Mikami H; Ogihara T
    Nihon Rinsho; 1989 Sep; 47(9):2035-40. PubMed ID: 2574242
    [No Abstract]   [Full Text] [Related]  

  • 23. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract]   [Full Text] [Related]  

  • 24. [Protective effect of alpha beta-blockers on hypertensive target-organ damage].
    Kai H; Imaizumi T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():587-90. PubMed ID: 15171441
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension].
    Sha K; Furuya H; Kuro M; Kitaguchi K; Yamagishi N; Marunaka S; Shimoyama J; Okuda T
    Masui; 1988 Jul; 37(7):830-5. PubMed ID: 2906709
    [No Abstract]   [Full Text] [Related]  

  • 26. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha beta-blockers for patients with hypertension].
    Mizuta Y; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():305-9. PubMed ID: 16981560
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-blockers in treatment of hypertension.
    Harris D; Richards DA
    Br Med J; 1978 Sep; 2(6141):894. PubMed ID: 30514
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
    Hanna W; Grell GA
    South Med J; 1980 May; 73(5):653-4. PubMed ID: 6103586
    [No Abstract]   [Full Text] [Related]  

  • 31. Giant, dopamine secreting thoracoabdominal neuroblastoma in a 2-year-old: rapid preoperative blockade with labetalol.
    Pappas L; Shamberger RC; Seefelder C
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):163-6. PubMed ID: 20147848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
    Frishman WH
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Labetalol in the preoperative management of phaeochromocytoma.
    Russell WJ; Kaines AH; Hooper MJ; Frewin DB
    Anaesth Intensive Care; 1982 May; 10(2):160-3. PubMed ID: 6125109
    [No Abstract]   [Full Text] [Related]  

  • 34. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
    Gyimesi A; Hanyecz V; Pocsay G; Iványi J
    Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined labetalol plus flunarizine treatment for arterial hypertension.
    Bonavita E
    Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid or multifactorial drugs in antihypertensive treatment.
    van Zwieten PA
    J Hypertens; 1990 Aug; 8(8):687-96. PubMed ID: 1976690
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacology of labetalol, an alpha- and beta-adrenoceptor blocking agent.
    Blakeley AG; Summers RJ
    Gen Pharmacol; 1978; 9(6):399-402. PubMed ID: 32121
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.